"
Page
Discussion
View source
History
teams
Log in
 
Team:SupBiotech-Paris/Bibliographie
From 2009.igem.org
Accueil
Équipe
Gestion de projet
Galerie
Remerciements
Projet
Introduction Thérapies actuelles Thérapies géniques Le DVS Concept Vecteur Tissulaire Vecteur Cellulaire Plasmide thérapeutique Conclusion Mise en application Ciblage Tissulaire Action antitumorale Modeling du traitement Conclusion
Ressources
BioBricks Matériel & Méthode Bibliographie
Ethique & sûreté
Éthique Sûreté
Contents
1 Thérapies
2 Vectorisation
3 Vecteur Tissulaire
4 Vecteur Cellulaire
5 Plasmide Thérapeutique
6 Action antitumorale
7 Ethique
8 Sûreté
Thérapies
Chapitre
Ref.
Auteurs
Titre
Année
Thérapie actuelle
[1]
Lechat P.
Pharmacology
2006
Thérapie actuelle
[2]
Bruguerolle B.
Biological rhythms and medications: a source of variability often neglected in pharmacology
2008
Thérapie genique
[1]
Kevin J. Scanlon and al.
Cancer Gene Therapy: Challenges and Opportunities
2004
Thérapie genique
[2]
Gouze JN and al.
A comparative study of the inhibitory effects of interleukin-1 receptor antagonist following administration as a recombinant protein or by gene transfer
2003
Thérapie génique
[3]
Centre for Genetics Education
http://www.genetics.com.au/index.asp
XXXX
Haut de page
Vectorisation
Chapitre
Ref.
Auteurs
Titre
Année
Vectorisation
[1]
Couvreur P.
L'encapsulation de médicament
2003
Vectorisation
[2]
Andrieux K. and al.
Nanotechnology and new drug
2003
Vectorisation
[3]
Torchilin V.P.
Recent Approaches to Intracellular Delivery of Drugs and DNA and Organelle Targeting
2006
Vectorisation
[4]
Davis M.E. and al.
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008
Vectorisation
[5]
Seow Y. and al.
Biological Gene Delivery Vehicles: Beyond Viral Vectors
2009
Vectorisation
[6]
Decroly E.
Vectorology
2005
Vectorisation
[7]
Robbins P.D. and al.
Viral Vectors for Gene Therapy
1998
Vectorisation
[8]
Wei M.Q. and al.
Bacterial targeted tumour therapy-dawn of a new era
2008
Vectorisation
[9]
Ryan R.M. and al.
Use of bacteria in anti-cancer therapies
2005
Vectorisation
[10]
Mehnert
Solid lipid nanoparticles: Production, characterization and applications
2001
Vectorisation
[11]
Lasic D.D.
Liposomes in gene therapy
1996
Vectorisation
[12]
Lutten J. and al.
Biodegradable polymers as non-viral carriers for plasmid DNA delivery
2008
Vectorisation
[13]
Jiskoot W. and al.
Immunological Risk of Injectable Drug Delivery Systems
2009
Vectorisation
[14]
Head M. and al.
Mechanism and computer simulation of immune complex formation, opsonization, and clearance
1996
Vectorisation
[15]
Koide H. and al.
Particle size-dependent triggering of accelerated blood clearance phenomenon
2008
Vectorisation
[16]
Ishida T. and al.
Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes
2005
Vectorisation
[17]
Wang XY and al.
Anti-PEG IgM elicited by injection of liposomes is involved in the enhanced blood clearance of a subsequent dose of PEGylated liposomes
2007
Vectorisation
[18]
Tosi M.F. and al.
Innate immune responses to infection
2005
Vectorisation
[19]
Linkov I and al.
Nanotoxicology and nanomedicine: making hard decisions
2008
Haut de page
Vecteur Tissulaire
Chapitre
Ref.
Auteurs
Titre
Année
Vecteur Tissulaire
[1]
Ronald S. and al.
Antimicrobial mechanisms of phagocytes and bacterial evasion strategies
2009
Vecteur Tissulaire
[2]
Clark B. Inderlied and al.
The Mycobacterium avium Complex
1993
Vecteur Tissulaire
[3]
Nisheeth Agarwal and al.
Cyclic AMP intoxication of macrophages by a Mycobacterium tuberculosis adenylate cyclase
2009
Vecteur Tissulaire
[4]
Hunter R.L. and al.
Pathology of postprimary tuberculosis in humans and mice: contradiction of long-held beliefs
2007
Vecteur Tissulaire
[5]
Axelrod S and al.
Delay of phagosome maturation by a mycobacterial lipid is reversed by nitric oxide
2008
Vecteur Tissulaire
[6]
Nicole N van der Wel and al.
Subcellular localization of mycobacteria in tissues and detection of lipid antigens in organelles using cryo-techniques for light and electron microscopy
2005
Vecteur Tissulaire
[7]
Claudia Nobrega and al.
The thymus as a target for mycobacterial infections
2007
Haut de page
Vecteur Cellulaire
Chapitre
Ref.
Auteurs
Titre
Année
Vecteur Cellulaire
[1]
Harrison Echols and al.
Genetic Map of Bacteriophage Lambda
1978
Vecteur Cellulaire
[2]
Joseph Sambrook and al.
Molecular Cloning: A Laboratory Manual (Third Edition)
2001
Vecteur Cellulaire
[3]
Court DL and al.
A New Look at Bacteriophage lambda Genetic Networks
2007
Vecteur Cellulaire
[4]
Ortega ME and al.
Bacteriophage Lambda gpNu1 and Escherichia coli IHF Proteins Cooperatively Bind and Bend Viral DNA: Implications for the Assembly of a Genome-Packaging Motor
2006
Vecteur Cellulaire
[5]
Feiss M. and al.
Bactériophage Lambda Terminase and the Mechanism of Viral DNA Packaging
2005
Vecteur Cellulaire
[6]
Hang JQ and al.
The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB
2001
Vecteur Cellulaire
[7]
Becker A and al.
Bacteriophage lambda DNA : The begginning of the End
1990
Vecteur Cellulaire
[8]
Hochschild A and al.
The bactériophage lambda cI protein finds an asymmetric solution
2009
Vecteur Cellulaire
[9]
Phoebe L.Stewart1 and al.
Cryo-EM visualization of an exposed RGD epitope on adenovirus that escapes antibody neutralization
1997
Haut de page
Plasmide Thérapeutique
Chapitre
Ref.
Auteurs
Titre
Année
Plasmide thérapeutique
[1]
Ortega ME et al.
Bacteriophage lambda gpNu1 and Escherichia coli IHF proteins cooperatively bind and bend viral DNA: implications for the assembly of a genome-packaging motor
2006
Plasmide thérapeutique
[2]
Joseph Sambrook and al.
Molecular Cloning: A Laboratory Manual (Third Edition)
2001
Plasmide thérapeutique
[3]
Court DL and al.
A New Look at Bacteriophage lambda Genetic Networks
2007
Plasmide thérapeutique
[4]
Feiss M. and al.
Viral Genome Packaging Machines: Genetics, Structure and Mechanism
2005
Plasmide thérapeutique
[5]
Hang JQ and al.
The Functional Asymmetry of cosN, the Nicking Site for Bacteriophage λ DNA Packaging, Is Dependent on the Terminase Binding Site, cosB
2001
Plasmide thérapeutique
[6]
Becker A and al.
Bacteriophage lambda DNA : The begginning of the End
1990
Plasmide thérapeutique
[7]
Young et al.
Effect of a DNA nuclear targeting sequence on gene transfer and expression of plasmids in the intact vasculature
2003
Haut de page
Action antitumorale
Chapitre
Ref.
Auteurs
Titre
Année
Action antitumorale
[1]
Chunlin Yang et al
Adenovirus-mediated Wild-Type p53 Expression Induces Apoptosis and Suppresses Tumorigenesis of Prostatic Tumor Cells
1995
Action antitumorale
[2]
Corrado Cirielli et al.
Adenovirus-mediated wild-type p53 expression induces apoptosis and suppresses tumorigenesis of experimental intracranial human malignant glioma
1999
Action antitumorale
[3]
Su-Ping Ren et al.
Adenoviral-mediated transfer of human wild-type p53, GM-CSF and B7-1 genes results in growth suppression and autologous anti-tumor cytotoxicity of multiple myeloma cells in vitro
2006
Action antitumorale
[4]
Zhao-hua Qiu et al
Growth suppression and immunogenicity enhancement of Hep-2 or primary laryngeal cancer cells by adenovirus-mediated co-transfer of human wild-type p53, granulocyte-macrophage colony-stimulating factor and B7-1 genes
2002
Action antitumorale
[5]
Zhao-hua Qiu et al.
Co-transfer of human wild-type p53 and granulocyte-macrophage colony-stimulating factor genes via recombinant adenovirus induces apoptosis and enhances immunogenicity in laryngeal cancer cells
2001
Action antitumorale
[6]
Markus Reiser et al.
Induction of cell proliferation arrest and apoptosis in hepatoma cells through adenoviral-mediated transfer of p53 gene
2000
Action antitumorale
[7]
Louis L. Pisters et al.
Evidence That Transfer of Functional p53 Protein Results in Increased Apoptosis in Prostate Cancer
2004
Action antitumorale
[8]
Susan C. Modesitt et al.
In Vitro and in Vivo Adenovirus-mediated p53 and p16 Tumor Suppressor Therapy in Ovarian Cancer
2001
Action antitumorale
[9]
Yong-song GUAN et al.
Adenovirus-mediated wild-type p53 gene transfer in combination with bronchial arterial infusion for treatment of advanced non-small-cell lung cancer, one year follow-up
2009
Haut de page
Ethique
Chapter
Ref.
Authors
Title
Year
Ethique
[1]
Joël Rosnay
Biologie de synthèse: Enjeux et défis pour l’humanité
2004
Ethique
[2]
Synbiosafe
http://www.synbiosafe.eu/forum/
2008
Ethique
[3]
Bernadette Bensaude Vincent, Dorothée Benoit-Browaeys
Petite typologie de la biologie synthétique et enjeux éthiques
2009
Ethique
[4]
Anna Deplazes Æ Markus Huppenbauer
Synthetic organisms and living machines
2004
Ethique
[5]
Schmidt M, Ganguli-Mitra A,and al.
A priority paper for the societal and ethical aspects of synthetic biology
2009
Ethique
[6]
Parens E, Johnston J, Moses J.
Ethics. Do we need "synthetic bioethics"?
2009
Back to top
Sûreté
Chapitre
Ref.
Auteurs
Titre
Année
Sûreté
[1]
Jonathan B. Tucker and al.
The Promise and Perils of Synthetic Biology
2006
Sûreté
[2]
Synbiosafe
http://www.synbiosafe.eu/forum/
2008
Sûreté
[3]
Vivagora
http://www.vivagora.org/IMG/pdf/CR-biosynth011009.pdf
2009
Sûreté
[4]
New Atlantis
http://www.thenewatlantis.com/publications/life-from-scratch
2004
Haut de page
Retrieved from " http://2009.igem.org/Team:SupBiotech-Paris/Bibliographie "
Recent changes
What links here
Related changes
Special pages
My preferences
Printable version
Permanent link
Privacy policy
Disclaimers
